Table 2.
GTQ-score for head and neck cancer patients before and after intervention and 3-year follow-up
| Before intervention | After intervention | 36-months follow-up | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTQ | I, n = 50 mean (CI) |
C, n = 50 mean (CI) |
p | I, n = 50 mean (CI) |
C, n = 50 mean (CI) |
p | I, n = 47 mean (CI) |
C, n = 43 mean (CI) |
p |
| Jaw-related problems | 41.4 (36–47) | 41.5 (35–48) | ns | 22.9 (17–29) | 43.1 (37–49) | *** | 9.0 (6–12) | 46.0 (39–53) | *** |
| Eating limitations | 46.5 (37–56) | 40.0 (33–47) | ns | 28.1 (21–35) | 39.5 (33–46) | * | 4.9 (3–7) | 46.4 (38–55) | *** |
| Muscular tension | 26.3 (22–31) | 23.8 (18–29) | ns | 13.2 (10–17) | 27.5 (22–33) | *** | 7.8 (5–11) | 40.3 (33–47) | *** |
| Facial pain right now | 24.3 (18–31) | 20.7 (14–27) | ns | 9.0 (4–14) | 20.7 (15–26) | *** | 2.5 (0–4) | 20.2 (15–26) | *** |
| Facial pain worst last month | 43.0 (36–51) | 40.3 (33–48) | ns | 22.7 (16–29) | 30.7 (24–38) | ns | 5.0 (3–7) | 27.5 (21–34) | *** |
| Facial pain average | 38.3 (32–45) | 35.3 (28–43) | ns | 21.0 (15–27) | 30.0 (23–37) | ns | 5.0 (2–7) | 25.6 (19–32) | *** |
| Facial pain social, leisure, and family activities | 24.0 (16–32) | 23.5 (16–31) | ns | 15.0 (7–23) | 20.0 (13–27) | ns | 0.5 (0–2) | 20.9 (14–28) | *** |
| Facial pain affecting ability to work | 25.0 (17–33) | 23.5 (15–32) | ns | 13.5 (6–21) | 21.0 (14–28) | * | 1.1 (0–3) | 18.0 (12–25) | *** |
| Limitation in opening mouth | 49.0 (43–55) | 45.0 (36–54) | ns | 33.0 (26–40) | 40.0 (33–47) | ns | 15.4 (11–20) | 43.0 (34–52) | *** |
| LOM social, leisure and family activities | 24.0 (18–30) | 24.5 (17–32) | ns | 16.5 (8–25) | 26.5 (20–33) | ** | 2.7 (0–5) | 22.1 (15–29) | *** |
| LOM affecting ability to work | 24.5 (16–33) | 25.0 (17–33) | ns | 14.0 (6–22) | 22.0 (15–30) | * | 2.1 (0–5) | 22.1 (15–29) | *** |
ns, not statistically significant; I, intervention group; C, control group; GTQ, Gothenburg Trismus Questionnaire; CI, 95% confidence interval; HNC, head and neck cancer; Domains and single items range 0–100, where 100 indicate maximal amount of symptoms and 0 is equal to no symptoms. P values for analysis of statistical significant difference in mean scores between the intervention group and the control group, before and after intervention and at 3-year follow-up
******p < 0.05, p < 0.01, p < 0.001